| Role of platelets and platelet receptors in cancer metastasis M Schlesinger Journal of hematology & oncology 11 (1), 125, 2018 | 600 | 2018 |
| Vascular cell adhesion molecule‐1 (VCAM‐1)—an increasing insight into its role in tumorigenicity and metastasis M Schlesinger, G Bendas International journal of cancer 136 (11), 2504-2514, 2015 | 267 | 2015 |
| Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases A Raynor, P Jantscheff, T Ross, M Schlesinger, M Wilde, S Haasis, ... Lipids in health and disease 14, 1-15, 2015 | 77 | 2015 |
| Contribution of very late antigen-4 (VLA-4) integrin to cancer progression and metastasis M Schlesinger, G Bendas Cancer and Metastasis Reviews 34, 575-591, 2015 | 70 | 2015 |
| A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies S Bisht, M Schlesinger, A Rupp, R Schubert, J Nolting, J Wenzel, ... Journal of nanobiotechnology 14, 1-15, 2016 | 61 | 2016 |
| Lysophosphatidylcholine pretreatment reduces VLA-4 and P-Selectin–mediated B16. F10 melanoma cell adhesion in vitro and inhibits metastasis-like lung invasion in vivo P Jantscheff, M Schlesinger, J Fritzsche, LA Taylor, R Graeser, G Kirfel, ... Molecular cancer therapeutics 10 (1), 186-197, 2011 | 61 | 2011 |
| VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes M Calin, D Stan, M Schlesinger, V Simion, M Deleanu, ... European Journal of Pharmaceutics and Biopharmaceutics 89, 18-29, 2015 | 59 | 2015 |
| β1-Integrin binding to collagen type 1 transmits breast cancer cells into chemoresistance by activating ABC efflux transporters F Baltes, V Pfeifer, K Silbermann, J Caspers, KW von Rekowski, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1867 (5), 118663, 2020 | 57 | 2020 |
| The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin M Schlesinger, M Roblek, K Ortmann, A Naggi, G Torri, L Borsig, ... Thrombosis research 133 (5), 855-862, 2014 | 52 | 2014 |
| Virulence‐associated protein A from Rhodococcus equi is an intercompartmental pH‐neutralising virulence factor K Von Bargen, M Scraba, I Krämer, M Ketterer, C Nehls, S Krokowski, ... Cellular microbiology 21 (1), e12958, 2019 | 51 | 2019 |
| Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cells DB Pfankuchen, DP Stölting, M Schlesinger, HD Royer, G Bendas Biochemical pharmacology 97 (2), 147-157, 2015 | 44 | 2015 |
| Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasis M Roblek, M Calin, M Schlesinger, D Stan, R Zeisig, M Simionescu, ... Journal of Controlled Release 220, 341-347, 2015 | 39 | 2015 |
| Binding between heparin and the integrin VLA-4 M Schlesinger, D Simonis, P Schmitz, J Fritzsche, G Bendas Thrombosis and haemostasis 102 (11), 816-822, 2009 | 39 | 2009 |
| The GPIb-IX complex on platelets: insight into its novel physiological functions affecting immune surveillance, hepatic thrombopoietin generation, platelet clearance and its … G Bendas, M Schlesinger Experimental hematology & oncology 11 (1), 19, 2022 | 37 | 2022 |
| The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives M Schlesinger, P Schmitz, R Zeisig, A Naggi, G Torri, B Casu, G Bendas Thrombosis research 129 (5), 603-610, 2012 | 35 | 2012 |
| Mechanisms of matrix-induced chemoresistance of breast cancer cells—deciphering novel potential targets for a cell sensitization B Jakubzig, F Baltes, S Henze, M Schlesinger, G Bendas Cancers 10 (12), 495, 2018 | 33 | 2018 |
| Glycosaminoglycans as tools to decipher the platelet tumor cell interaction: a focus on P-selectin S Schwarz, LM Gockel, A Naggi, U Barash, M Gobec, G Bendas, ... Molecules 25 (5), 1039, 2020 | 31 | 2020 |
| Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathway DB Pfankuchen, F Baltes, T Batool, JP Li, M Schlesinger, G Bendas Oncotarget 8 (40), 67553, 2017 | 29 | 2017 |
| The molecular mechanism by which saturated lysophosphatidylcholine attenuates the metastatic capacity of melanoma cells T Ross, B Jakubzig, M Grundmann, U Massing, E Kostenis, M Schlesinger, ... FEBS open bio 6 (12), 1297-1309, 2016 | 29 | 2016 |
| Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β1-Integrin Emerges as a Key Factor for Breast Cancer Chemosensitization upon … F Baltes, J Caspers, S Henze, M Schlesinger, G Bendas International Journal of Molecular Sciences 21 (14), 4956, 2020 | 27 | 2020 |
